期刊文献+

NK细胞抑制CD34^+早期急性髓系白血病细胞克隆形成 被引量:3

Cytotoxicity of allogenetic NK cells against CD34^+ early acute myelogenous leukemia cells
下载PDF
导出
摘要 目的探讨同种异体NK细胞对CD34+早期急性髓系白血病细胞的克隆抑制效应。方法免疫磁珠法分离5例健康个体NK细胞,甲基纤维素克隆形成实验检测NK细胞对KG1a细胞杀伤后的克隆形成,同时与NK杀伤敏感细胞株K562比较。结果急性髓系白血病细胞株KG1a中CD34抗原表达率为(98.0±1.1)%,分选后的NK细胞(CD3-CD16+CD56+细胞)纯度为(93.2±3.7)%。不同效靶比时NK细胞对KG1a细胞均能抑制其克隆形成。随着效靶比的增高,其克隆抑制率随之增高(P<0.05)。同一效靶比时,NK细胞对KG1a的克隆抑制率低于K562,差异有显著性(P<0.05)。结论同种异体NK细胞对CD34+早期急性髓系白血病细胞的克隆形成具有一定的抑制作用。 Objective To study the in vitro clone inhibition rate of allogenetic NK ceils on human CD34^+ early acute myelogenous leukemia cells. Methods The expression of CD34 antigen on acute myelogenous leukemia cell line - KG1a cells was detected by FACS. Clone inhibition rate of NK cells isolated from 5 healthy persons with MACS was detected by calculation of methylcellulose at different effect -to -target (E:T) ratios compared with K562 which is sensitive to NK cells. Results The expression rate of CD34 antigen on KG1a cells was (98.0 ± 1.1 ) % and purify of isolated NK cells ( CD3^- CD16^+ CD56^+ cells) was (93.2 ± 3.7 ) % detected by FACS. There was in vitro clone inhibition of allogenetic NK cells against KG1 a cells at different E :T ratios. With increasing E: T ratios, clone inhibition rate of allogenetic NK cells against KGla cells increased. With same E: T ratios, clone inhibition rate against KGla cells was lower than that against K562 cells ( P 〈 0.05 ). Conclusion Allogenetic NK cells displayed clone inhibition against CD34^+ early acute myelogenous leukemia cells.
出处 《广东医学》 CAS CSCD 北大核心 2008年第1期31-33,共3页 Guangdong Medical Journal
基金 国家自然科学基金资助项目(编号:30471636)
关键词 NK细胞 早期急性髓系白血病细胞 克隆抑制 NK cell Early acute myelogenous leukemia Clone inhibition
  • 相关文献

参考文献9

  • 1GUIMARAES F,GUVEN H,DONATI D,et al.Evaluation of ex vivo expanded human NK cells on antileukemia activity in SCID -beige mice[J].Leukemia,2006,20(5):833-839.
  • 2FURLEY A J,REEVES B R,MIZUTANI S,et al.Divergent Molecular Phenotypes of KG1 and KG1a myeloid cell lines[J].Blood,1986,68(5):1 101-1 107.
  • 3FARAGS S,VANDEUSEN J B,FEHNIGER T A,et al.Biology and clinic impact of human natural killer cells[J].Int J Hematol,2003,78(1):7 -17.
  • 4BAUER S,GROH V,WU J,et al.Activation of NKcells and T cells by NKG2D,a receptor for stress inducible MICA[J].Science,1999,285(5428):727 -729.
  • 5MILLER J S,SOIGNIER Y,PANOSKALTSIS-MORTARI A,et al.Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer[J].Blood,2005,105(8):3 051 -3 057.
  • 6梅家转,郭坤元,魏红梅,常红,宋朝阳.NKG2D配体在鼻咽癌细胞的表达及其对NK细胞杀伤活性的影响[J].中华微生物学和免疫学杂志,2006,26(12):1068-1069. 被引量:4
  • 7梅家转,牛新清,郭坤元,周健,魏红梅.K562和K562/AO2细胞HLA I类分子与MICA/B的表达及其对NK细胞杀伤活性的影响[J].中国实验血液学杂志,2007,15(2):288-291. 被引量:10
  • 8柏树令,赵丹.CD34抗原的生物学特性及其临床应用[J].解剖科学进展,2005,11(1):54-56. 被引量:40
  • 9SCONOCCHIA G,LAU M,PROVENANO M,et al.The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions[J].Blood,2005,106(10):3 666 -3 672.

二级参考文献20

  • 1栾凤君,杨纯正.一株人红白血病多药耐药细胞系(K562/A02)的建立及其耐药特性...[J].中华肿瘤杂志,1993,15(2):101-103. 被引量:68
  • 2邹萍,向建平,陈智超,李崇渔.急性髓系白血病细胞CD_(34)抗原表达的研究Ⅰ表达特点和临床意义[J].中华血液学杂志,1994,15(7):339-341. 被引量:28
  • 3操州虹,刘秀芳,王辨明.不同病期慢性粒细胞白血病CD_(34)阳性细胞的临床意义[J].中华血液学杂志,1996,17(1):10-12. 被引量:3
  • 4Osawa M,Hanada K, Hamada H, et al. Long-term lymphohematopoietic reconstitution by a single CD34 - low/negative hematopietic stem cell [J]. Science, 1996,273 (5272): 242 - 245.
  • 5Huss R. CD34 - stem cells as the earliest precursors of hempatopoietic progeny[J]. Exp Hematol,1998,26(11) :1022 - 1023.
  • 6Halens S, Kohn DB. Gene therapy using hematopoietic stem cells:sisyphus approaches the cerst[J]. Human Gene Therapy,2000,11(9) :1259 - 1267.
  • 7Cornelissen JJ, Vander Hdt B, Petersen EJ, et al. A randomized multicenter comparison of CD34 +-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies [J]. Exp Hematol,2003,31 (10) :855 -864.
  • 8Vogle W, Behringer D, Scheding S, et al. Ex vivo expansion of CD34 + peripheral blood progenitor cells: implications for the expansion of contaminating epithelial tumor cells[J]. Blood,1996,88(7) :2707 -2713.
  • 9Brugger W, Heimfeld S, Berenson RJ, et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo[J]. N Eng J Med, 1995,333 (5) :283 -287.
  • 10Harraz M, Jiao C, Hanlon HD, et al. CD34- blood-derived human endothelial cell progenitors[J]. Stem Gells,2001,19(4) :304-312.

共引文献48

同被引文献27

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部